CRP and metabolic dysfunction-associated steatotic liver disease: Moreover, excessive inflammatory cytokines release, mediated by the hepato-cytotoxic injury [38], might constitute a target for probiotics’ anti-inflammatory properties, as probiotics were shown to decrease not only ALT values but also CRP levels in non-alcoholic fatty liver disease (NAFLD) subjects [39].